Acura Pharmaceuticals, Inc. Stock
Stocks
ACUR
US00509L8028
Biotechnology & Medical Research
OTC Markets Traded|
Real-time
OTC Markets
18:49:12 20/04/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | -80.00% |
|
-.--% | -80.00% |
| Market Cap | 3.28M 2.89M 2.74M 2.48M 4.65M 315M 4.7M 32.84M 12.66M 161M 12.31M 12.04M 517M | P/E 2020 |
-5.25x | P/E 2021 | -25x |
|---|---|---|---|---|---|
| Enterprise Value | 3.41M 3.01M 2.85M 2.58M 4.85M 328M 4.89M 34.19M 13.18M 167M 12.82M 12.54M 538M | EV / Sales 2020 |
2.91x | EV / Sales 2021 | 20.9x |
| Free-Float |
98.31% | Yield 2020 * |
-
| Yield 2021 | - |
| 1 day | -80.00% | ||
| Current month | -0.99% | ||
| 1 month | -0.99% | ||
| 3 months | -88.89% | ||
| 6 months | -99.00% | ||
| Current year | -80.00% |
| 1 week | 0 |  | 0 |
| 1 month | 0 | | 0 |
| Current year | 0 | | 0.01 |
| 1 year | 0 | | 0.01 |
| 3 years | 0 | | 0.75 |
| 5 years | 0 | | 0.75 |
| 10 years | 0 | | 1.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Jones
CEO | Chief Executive Officer | 67 | 01/04/2011 |
Bob Seiser
DFI | Director of Finance/CFO | 62 | 01/08/2024 |
Albert Brzeczko
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/02/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
William Skelly
CHM | Chairman | 75 | 01/10/1996 |
| Director/Board Member | 55 | 01/12/2002 | |
Bruce Wesson
BRD | Director/Board Member | 83 | 01/03/1998 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 02/01/26 | Exercice | Director | 150,000 | 0.2273% | ||
| 02/01/26 | Exercice | Director | 150,000 | 0.2273% | ||
| 02/01/26 | Exercice | Director | 150,000 | 0.2273% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -80.00% | -.--% | -50.00% | -75.00% | 6.73K | |
| -0.70% | -4.35% | +56.10% | +86.42% | 71.81B | |
| +0.45% | -0.82% | +38.81% | +84.19% | 60.06B | |
| +0.19% | +0.94% | +36.97% | +21.32% | 27.93B | |
| -1.60% | -4.32% | -18.39% | +357.82% | 25.7B | |
| -1.08% | -2.91% | -0.17% | -9.86% | 24.89B | |
| +0.65% | +1.67% | +26.47% | -7.62% | 20.92B | |
| +3.46% | +3.91% | +158.90% | +337.81% | 15.04B | |
| -0.38% | -0.43% | +42.72% | +164.99% | 14.46B | |
| +3.91% | -4.56% | -2.71% | +506.41% | 13.87B | |
| Average | -7.53% | -0.82% | +28.87% | +146.65% | 27.47B | |
| Weighted average by Cap. | +0.09% | -1.74% | +38.01% | +127.93% |
| 2020 | 2021 | |
|---|---|---|
| Net sales | 3.57M 3.15M 2.98M 2.7M 5.07M 343M 5.12M 35.76M 13.78M 175M 13.41M 13.11M 563M | 1.56M 1.38M 1.31M 1.18M 2.22M 150M 2.24M 15.66M 6.03M 76.59M 5.87M 5.74M 246M |
| Net income | -1.21M -1.07M -1.01M -915K -1.71M -116M -1.73M -12.1M -4.66M -59.19M -4.54M -4.44M -190M | -879K -776K -734K -666K -1.25M -84.35M -1.26M -8.8M -3.39M -43.07M -3.3M -3.23M -139M |
| Net Debt | 5.86M 5.17M 4.89M 4.43M 8.31M 562M 8.4M 58.66M 22.61M 287M 21.99M 21.51M 923M | 135K 119K 113K 102K 192K 12.95M 194K 1.35M 521K 6.61M 507K 496K 21.29M |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/09/26 | $0.000101 | -.--% | 300 |
| 24/09/26 | $0.000101 | +1.00% | 1,050 |
- Stock Market
- Stocks
- ACUR Stock
Select your edition
All financial news and data tailored to specific country editions
